Similar articles

• [The role of expression of histocompatibility antigens class II (HLA-D) and interleukin-2 receptor in the process of rejection of transplanted organs. I].

  Nowaczyk M. Nowaczyk M. Pol Arch Med Wewn. 1989 Oct-Dec;82(4-6):190-4. Pol Arch Med Wewn. 1989. PMID: 2518392 Review. Polish. No abstract available.
• Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants.

  Middleton D, Mytilineos Y, Savage D, Ferrara GB, Angelini G, Amoroso A, Trainor F, Gaweco A, Mazzola G, Delfino L, et al. Middleton D, et al. Transplant Proc. 1992 Dec;24(6):2439-40. Transplant Proc. 1992. PMID: 1361255 No abstract available.
• Nonradioactive DNA/RFLP analysis for HLA DR and DQ allotypes.

  Crosby I, Beales P, Barnes RM. Crosby I, et al. Transplant Proc. 1992 Dec;24(6):2481-2. Transplant Proc. 1992. PMID: 1361259 No abstract available.
• Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.

  Cross AR, Lion J, Loiseau P, Charron D, Taupin JL, Glotz D, Mooney N. Cross AR, et al. Hum Immunol. 2016 Nov;77(11):1092-1100. doi: 10.1016/j.humimm.2016.04.003. Epub 2016 Apr 6. Hum Immunol. 2016. PMID: 27060781 Review.
• Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants.

  Rosenberg WM, Bushell A, Higgins RM, Wordsworth BP, Wood KJ, Bell JI, Morris PJ. Rosenberg WM, et al. Hum Immunol. 1992 Jan;33(1):5-9. doi: 10.1016/0198-8859(92)90045-o. Hum Immunol. 1992. PMID: 1548149